866-997-4948(US-Canada Toll Free)

Global Anti-Obesity Drugs Sales Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 125 Pages

Notes:
Sales, means the sales volume of Anti-Obesity Drugs
Revenue, means the sales value of Anti-Obesity Drugs

This report studies sales (consumption) of Anti-Obesity Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Anti-Obesity Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Prescription Drugs
OTC Drugs
Split by applications, this report focuses on sales, market share and growth rate of Anti-Obesity Drugs in each application, can be divided into
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

Table of Contents

Global Anti-Obesity Drugs Sales Market Report 2017
1 Anti-Obesity Drugs Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Classification of Anti-Obesity Drugs
1.2.1 Prescription Drugs
1.2.2 OTC Drugs
1.3 Application of Anti-Obesity Drugs
1.3.1 6-18 Callant
1.3.2 18-30 Adult
1.3.3 30-60Middle-Aged
1.3.4 Others
1.4 Anti-Obesity Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Anti-Obesity Drugs (2012-2022)
1.5.1 Global Anti-Obesity Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)

2 Global Anti-Obesity Drugs Competition by Manufacturers, Type and Application
2.1 Global Anti-Obesity Drugs Market Competition by Manufacturers
2.1.1 Global Anti-Obesity Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Anti-Obesity Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Anti-Obesity Drugs (Volume and Value) by Type
2.2.1 Global Anti-Obesity Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Anti-Obesity Drugs (Volume and Value) by Regions
2.3.1 Global Anti-Obesity Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Anti-Obesity Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Anti-Obesity Drugs (Volume) by Application

3 United States Anti-Obesity Drugs (Volume, Value and Sales Price)
3.1 United States Anti-Obesity Drugs Sales and Value (2012-2017)
3.1.1 United States Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Anti-Obesity Drugs Sales Price Trend (2012-2017)
3.2 United States Anti-Obesity Drugs Sales and Market Share by Manufacturers
3.3 United States Anti-Obesity Drugs Sales and Market Share by Type
3.4 United States Anti-Obesity Drugs Sales and Market Share by Application

4 China Anti-Obesity Drugs (Volume, Value and Sales Price)
4.1 China Anti-Obesity Drugs Sales and Value (2012-2017)
4.1.1 China Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Anti-Obesity Drugs Sales Price Trend (2012-2017)
4.2 China Anti-Obesity Drugs Sales and Market Share by Manufacturers
4.3 China Anti-Obesity Drugs Sales and Market Share by Type
4.4 China Anti-Obesity Drugs Sales and Market Share by Application

5 Europe Anti-Obesity Drugs (Volume, Value and Sales Price)
5.1 Europe Anti-Obesity Drugs Sales and Value (2012-2017)
5.1.1 Europe Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Anti-Obesity Drugs Sales Price Trend (2012-2017)
5.2 Europe Anti-Obesity Drugs Sales and Market Share by Manufacturers
5.3 Europe Anti-Obesity Drugs Sales and Market Share by Type
5.4 Europe Anti-Obesity Drugs Sales and Market Share by Application

6 Japan Anti-Obesity Drugs (Volume, Value and Sales Price)
6.1 Japan Anti-Obesity Drugs Sales and Value (2012-2017)
6.1.1 Japan Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Anti-Obesity Drugs Sales Price Trend (2012-2017)
6.2 Japan Anti-Obesity Drugs Sales and Market Share by Manufacturers
6.3 Japan Anti-Obesity Drugs Sales and Market Share by Type
6.4 Japan Anti-Obesity Drugs Sales and Market Share by Application
7 Southeast Asia Anti-Obesity Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Anti-Obesity Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Anti-Obesity Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Anti-Obesity Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Anti-Obesity Drugs Sales and Market Share by Type
7.4 Southeast Asia Anti-Obesity Drugs Sales and Market Share by Application
8 India Anti-Obesity Drugs (Volume, Value and Sales Price)
8.1 India Anti-Obesity Drugs Sales and Value (2012-2017)
8.1.1 India Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Anti-Obesity Drugs Sales Price Trend (2012-2017)
8.2 India Anti-Obesity Drugs Sales and Market Share by Manufacturers
8.3 India Anti-Obesity Drugs Sales and Market Share by Type
8.4 India Anti-Obesity Drugs Sales and Market Share by Application

9 Global Anti-Obesity Drugs Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Anti-Obesity Drugs Product Type, Application and Specification
9.1.2.1 Prescription Drugs
9.1.2.2 OTC Drugs
9.1.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Merck
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Anti-Obesity Drugs Product Type, Application and Specification
9.2.2.1 Prescription Drugs
9.2.2.2 OTC Drugs
9.2.3 Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 F.Hoffmann-La Roche
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Anti-Obesity Drugs Product Type, Application and Specification
9.3.2.1 Prescription Drugs
9.3.2.2 OTC Drugs
9.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Anti-Obesity Drugs Product Type, Application and Specification
9.4.2.1 Prescription Drugs
9.4.2.2 OTC Drugs
9.4.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 AstraZeneca
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Anti-Obesity Drugs Product Type, Application and Specification
9.5.2.1 Prescription Drugs
9.5.2.2 OTC Drugs
9.5.3 AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Boehringer Ingelheim
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Anti-Obesity Drugs Product Type, Application and Specification
9.6.2.1 Prescription Drugs
9.6.2.2 OTC Drugs
9.6.3 Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Anti-Obesity Drugs Product Type, Application and Specification
9.7.2.1 Prescription Drugs
9.7.2.2 OTC Drugs
9.7.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Eisai
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Anti-Obesity Drugs Product Type, Application and Specification
9.8.2.1 Prescription Drugs
9.8.2.2 OTC Drugs
9.8.3 Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Norgine
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Anti-Obesity Drugs Product Type, Application and Specification
9.9.2.1 Prescription Drugs
9.9.2.2 OTC Drugs
9.9.3 Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Arena Pharmaceuticals
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Anti-Obesity Drugs Product Type, Application and Specification
9.10.2.1 Prescription Drugs
9.10.2.2 OTC Drugs
9.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Orexigen Therapeutics
9.12 Vivus
9.13 Alizyme
9.14 Rhythm Pharmaceuticals
9.15 Shionogi
9.16 Zafgan

10 Anti-Obesity Drugs Maufacturing Cost Analysis
10.1 Anti-Obesity Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Anti-Obesity Drugs
10.3 Manufacturing Process Analysis of Anti-Obesity Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Anti-Obesity Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Anti-Obesity Drugs Market Forecast (2017-2022)
14.1 Global Anti-Obesity Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Anti-Obesity Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Anti-Obesity Drugs Price and Trend Forecast (2017-2022)
14.2 Global Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Anti-Obesity Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Anti-Obesity Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Anti-Obesity Drugs
Table Classification of Anti-Obesity Drugs
Figure Global Sales Market Share of Anti-Obesity Drugs by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Applications of Anti-Obesity Drugs
Figure Global Sales Market Share of Anti-Obesity Drugs by Application in 2015
Figure 6-18 Callant Examples
Figure 18-30 Adult Examples
Figure 30-60Middle-Aged Examples
Figure Others Examples
Figure United States Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Figure China Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Figure India Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Figure Global Anti-Obesity Drugs Sales and Growth Rate (2012-2022)
Figure Global Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Table Global Anti-Obesity Drugs Sales of Key Manufacturers (2012-2017)
Table Global Anti-Obesity Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Anti-Obesity Drugs Sales Share by Manufacturers
Figure 2016 Anti-Obesity Drugs Sales Share by Manufacturers
Table Global Anti-Obesity Drugs Revenue by Manufacturers (2012-2017)
Table Global Anti-Obesity Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Anti-Obesity Drugs Revenue Share by Manufacturers
Table 2016 Global Anti-Obesity Drugs Revenue Share by Manufacturers
Table Global Anti-Obesity Drugs Sales and Market Share by Type (2012-2017)
Table Global Anti-Obesity Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Type (2012-2017)
Figure Global Anti-Obesity Drugs Sales Growth Rate by Type (2012-2017)
Table Global Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
Table Global Anti-Obesity Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Type (2012-2017)
Figure Global Anti-Obesity Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Anti-Obesity Drugs Sales and Market Share by Regions (2012-2017)
Table Global Anti-Obesity Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Regions (2012-2017)
Figure Global Anti-Obesity Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Anti-Obesity Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Anti-Obesity Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Regions (2012-2017)
Figure Global Anti-Obesity Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Anti-Obesity Drugs Sales and Market Share by Application (2012-2017)
Table Global Anti-Obesity Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Application (2012-2017)
Figure Global Anti-Obesity Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
Figure United States Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Figure United States Anti-Obesity Drugs Sales Price Trend (2012-2017)
Table United States Anti-Obesity Drugs Sales by Manufacturers (2012-2017)
Table United States Anti-Obesity Drugs Market Share by Manufacturers (2012-2017)
Table United States Anti-Obesity Drugs Sales by Type (2012-2017)
Table United States Anti-Obesity Drugs Market Share by Type (2012-2017)
Table United States Anti-Obesity Drugs Sales by Application (2012-2017)
Table United States Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure China Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
Figure China Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Figure China Anti-Obesity Drugs Sales Price Trend (2012-2017)
Table China Anti-Obesity Drugs Sales by Manufacturers (2012-2017)
Table China Anti-Obesity Drugs Market Share by Manufacturers (2012-2017)
Table China Anti-Obesity Drugs Sales by Type (2012-2017)
Table China Anti-Obesity Drugs Market Share by Type (2012-2017)
Table China Anti-Obesity Drugs Sales by Application (2012-2017)
Table China Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure Europe Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Anti-Obesity Drugs Sales Price Trend (2012-2017)
Table Europe Anti-Obesity Drugs Sales by Manufacturers (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Manufacturers (2012-2017)
Table Europe Anti-Obesity Drugs Sales by Type (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Type (2012-2017)
Table Europe Anti-Obesity Drugs Sales by Application (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure Japan Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
Figure Japan Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Anti-Obesity Drugs Sales Price Trend (2012-2017)
Table Japan Anti-Obesity Drugs Sales by Manufacturers (2012-2017)
Table Japan Anti-Obesity Drugs Market Share by Manufacturers (2012-2017)
Table Japan Anti-Obesity Drugs Sales by Type (2012-2017)
Table Japan Anti-Obesity Drugs Market Share by Type (2012-2017)
Table Japan Anti-Obesity Drugs Sales by Application (2012-2017)
Table Japan Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Obesity Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Anti-Obesity Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Anti-Obesity Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Anti-Obesity Drugs Sales by Type (2012-2017)
Table Southeast Asia Anti-Obesity Drugs Market Share by Type (2012-2017)
Table Southeast Asia Anti-Obesity Drugs Sales by Application (2012-2017)
Table Southeast Asia Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure India Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
Figure India Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Figure India Anti-Obesity Drugs Sales Price Trend (2012-2017)
Table India Anti-Obesity Drugs Sales by Manufacturers (2012-2017)
Table India Anti-Obesity Drugs Market Share by Manufacturers (2012-2017)
Table India Anti-Obesity Drugs Sales by Type (2012-2017)
Table India Anti-Obesity Drugs Market Share by Type (2012-2017)
Table India Anti-Obesity Drugs Sales by Application (2012-2017)
Table India Anti-Obesity Drugs Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Anti-Obesity Drugs Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Anti-Obesity Drugs Global Market Share (2012-2017)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Global Market Share (2012-2017)
Table Eisai Basic Information List
Table Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Anti-Obesity Drugs Global Market Share (2012-2017)
Table Norgine Basic Information List
Table Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Norgine Anti-Obesity Drugs Global Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Global Market Share (2012-2017)
Table Orexigen Therapeutics Basic Information List
Table Vivus Basic Information List
Table Alizyme Basic Information List
Table Rhythm Pharmaceuticals Basic Information List
Table Shionogi Basic Information List
Table Zafgan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Anti-Obesity Drugs Sales Forecast by Regions (2017-2022)
Table Global Anti-Obesity Drugs Sales Forecast by Type (2017-2022)
Table Global Anti-Obesity Drugs Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *